|
Press Releases
December 2011
December 21, 2011
 RADIENT PHARMA Expands Distribution Of Onko-Sure® In Asia; Receives Payment On First Order Of 60 Kits
December 20, 2011
RADIENT PHARMA Announces 2012 Sales, Advertising & Outreach Plan
December 13, 2011
RADIENT PHARMA Launches New Onko-Sure® Website, Facebook And Twitter Outreach
December 8, 2011
RADIENT PHARMA Submits An Abstract To The American Society Of Colon And Rectal Surgeons
December 5, 2011
RADIENT PHARMA Two Abstracts Submitted To 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility In Colorectal Cancer Are Accepted For Presentation
November 2011
November 29, 2011
RADIENT PHARMA Completes Restructurings With Institutional Investors To Limit Conversions And Stock Sales And Provide For Potential Additional Capital
November 15, 2011
RADIENT PHARMA Asks DHS Holding Co. To Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
November 14, 2011
RADIENT PHARMA Announces FY 2011 Third Quarter Results
November 4, 2011
RADIENT PHARMA Announces Proxy Resolutions Approved At Special Meeting Of Stockholders
October 2011
October 24, 2011
RADIENT PHARMA Files Patents In Japan And China
October 20, 2011
RADIENT PHARMA Announces Dismisal Of Lawsuit On Its CIT Cancer Theraputic Technology
October 4, 2011
RADIENT PHARMA Launches U.S. National Marketing Campaign For Onko-Sure® Colorectal Cancer Test
September 2011
September 27, 2011
RADIENT PHARMA Onko-Sure® Is National Sponser For Get Your Rear In Gear® Colorectal Cancer Grassroots Organization
September 26, 2011
RADIENT PHARMA Signs Agreement With TS Pharm To Launch And Distribute Onko-Sure® In Central America And The Caribbean
September 20, 2011
RADIENT PHARMA Submits Two Abstracts To The American Society Of Clinical Oncologists On The Increased Sensitivity Of Onko-Sure® Combined With CEA For Colorectal Cancer Detection
September 14, 2011
RADIENT PHARMA Files International Patents In Australia And New Zealand
August 2011
August 23, 2011
RADIENT PHARMA Ships Onko-Sure® Test Kits To Brazil And Files Patent In Brazil
August 22, 2011
RADIENT PHARMA Appoints Biotech Executive Dr. Leonard Reyno To Its Board of Directors
August 19, 2011
RADIENT PHARMA Conducts Annual Shareholder Meeting
August 15, 2011
RADIENT PHARMA Announces FY2011 Second Quarter Results
August 11, 2011
RADIENT PHARMA Onko-Sure® Cancer Test Available Through NeoloMed BioSciences
August 4, 2011
RADIENT PHARMA Enters Distribution Agreement With Uni Pharma For Onko-Sure® Sales In Taiwan
July 2011
July 21, 2011
RADIENT PHARMA Participates In American Association Of Clinical Chemists Annual Meeting And Clinical Lab Expo
July 19, 2011
RADIENT PHARMA Annual Shareholders Meeting Scheduled For August 19, 2011
July 14, 2011
RADIENT PHARMA Selects RCRI As Reimbursement Specialist
July 13, 2011
RADIENT PHARMA Issues Corporate Report
July 7, 2011
RADIENT PHARMA Onko-Sure® Is Proven Effective In Early Detection Of Lung Cancer
July 6, 2011
RADIENT PHARMA Appoints Dilek Mir As Director Of Business Development And Investor Relations
June 2011
June 23, 2011
RADIENT PHARMA To Commence Trading On The OTCQX
June 22, 2011
RADIENT PHARMA To Exhibit At The National Conference For Colon Cancer Alliance
June 8, 2011
RADIENT PHARMA Announces FY 2011 First Quarter Results
June 2, 2011
RADIENT PHARMA Addresses Default Of FY2010 Notes
May 2011
May 26, 2011
RADIENT PHARMA Receives Non-Compliance Notice From NYSE AMEX
May 25, 2011
RADIENT PHARMA Files 10-K; Announces Fiscal 2010 Year End Results
May 24, 2011
RADIENT PHARMA Provides Update Regarding 2010 Form 10K & FY 2011 Q1 10Q
May 17, 2011
RADIENT PHARMA To Exhibit Onko-Sure® Cancer Test At The American Society Of Clinical Oncology (ASCO) Annual Meeting
May 17, 2011
RADIENT PHARMA Announces Settlement Reached With FY2009 Q4 Note Holders; Files Late Notification For 10Q
May 13, 2011
RADIENT PHARMA Addresses Default Of FY2011 Q1 Notes
April 2011
April 28, 2011
RADIENT PHARMA Receives Non-Compliance Notice From NYSE AMEX Regarding Its 10-K Filing
April 28, 2011
RADIENT PHARMA Executive Management To Present At The 2011 AEGIS Capital Emerging Growth Conference In Las Vegas April 28, 2011
April 27, 2011
RADIENT PHARMA Announces Results For U.S. Clinical Trial Of Onko-Sure® For Colorectal Cancer
April 21, 2011
NYSE AMEX Panel Grants Radient Pharmaceuticals' Request For Continued Compliance Period
April 18, 2011
RADIENT PHARMA Provides Update Regarding 2010 Form 10K; Anticipated Results & NYSE AMEX Hearing
March 2011
March 31, 2011
RADIENT PHARMA Announces Preliminary Results From Its Onko-Sure® Clinical Study
March 22, 2011
RADIENT PHARMA Receives Additional Deficiency Notice From NYSE AMEX
March 17, 2011
RADIENT PHARMA Hires DLA Piper To Defend Company Against Class Action Lawsuit
March 8, 2011
RADIENT PHARMA Confirms Study For Its Onko-Sure® In Vitro Diagnostic Cancer Test
March 8, 2011
RADIENT PHARMA Issues Statement On 'TheStreet.Com' Article
February 2011
February 23, 2011
RADIENT PHARMA Announces Appointment Of Dr. Robert L. Rooks DVM, MS To Its Board of Directors
February 3, 2011
RADIENT PHARMA Deconsolidated Subsidiary Jade Pharmaceuticals Inc. Closes $900,000 Bridge Financing
February 2, 2011
RADIENT PHARMA Completes Private Placement Of Private Financing With Gross Proceeds Of $7.5 Million
January 2011
January 31, 2011
RADIENT PHARMA Announces Signing Of Definitive Agreement For Private Placement Of $8.4 Million Convertible Notes And Warrants Financing
January 26, 2011
RADIENT PHARMA Receives NYSE AMEX Delisting Notice For Non-Compliance
January 25, 2011
RADIENT PHARMA Wholly-Owned Subsidiary NuVax Therapeutics Signs Exclusive License Agreement For Immune-Gene Therapeutics Technology From University Of Florida Research Center
January 20, 2011
RADIENT PHARMA Receives Updated European Union Certification For Onko-Sure®; CE Mark Opens Large Market For Company's IVD Cancer Test
January 19, 2011
The Biotechnology Industry Organization Announces Radient Pharmaceuticals Selected To Present At 8th Annual Bio Asia International Partnering Conference January 24-25, 2011
January 11, 2011
RADIENT PHARMA Comments On Recent News Of J&J's Planned Cancer Test; Announces Growing Worldwide Availability Of Its Onko-Sure® Cancer Test
January 7, 2011
RADIENT PHARMA Receives NYSE AMEX Approval For Debt To Equity Exchange
January 5, 2011
RADIENT PHARMA And Gaur Diagno Launch Cancer Education And Public Screening Program In India To Reach 2.2 Million People
January 4, 2011
RADIENT PHARMA Addresses January 4, 2011 Unusual Market Activity
|
